First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
07 2022
Historique:
revised: 28 02 2022
received: 08 02 2022
accepted: 01 03 2022
pubmed: 5 3 2022
medline: 21 5 2022
entrez: 4 3 2022
Statut: ppublish

Résumé

The SARS-CoV-2 21K/BA.1, 21L/BA.2, and BA.3 Omicron variants have recently emerged worldwide. To date, the 21L/BA.2 Omicron variant has remained very minority globally but became predominant in Denmark instead of the 21K/BA.1 variant. Here, we describe the first cases diagnosed with this variant in south-eastern France. We identified 13 cases using variant-specific qPCR and next-generation sequencing between 28/11/2021 and 31/01/2022, the first two cases being diagnosed in travelers returning from Tanzania. Overall, viral genomes displayed a mean (±standard deviation) number of 65.9 ± 2.5 (range, 61-69) nucleotide substitutions and 31.0 ± 8.3 (27-50) nucleotide deletions, resulting in 49.6 ± 2.2 (45-52) amino acid substitutions (including 28 in the spike protein) and 12.4 ± 1.1 (12-15) amino acid deletions. Phylogeny showed the distribution in three different clusters of these genomes, which were most closely related to genomes from England and South Africa, from Singapore and Nepal, or from France and Denmark. Structural predictions highlighted a significant enlargement and flattening of the surface of the 21L/BA.2 N-terminal domain of the spike protein compared to that of the 21K/BA.1 Omicron variant, which may facilitate initial viral interactions with lipid rafts. Close surveillance is needed at global, country, and center scales to monitor the incidence and clinical outcome of the 21L/BA.2 Omicron variant.

Identifiants

pubmed: 35243660
doi: 10.1002/jmv.27695
pmc: PMC9088623
doi:

Substances chimiques

Nucleotides 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3421-3430

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Nature. 2021 Jul;595(7869):713-717
pubmed: 34192736
Nature. 2022 Feb;602(7895):26-28
pubmed: 35091701
J Med Virol. 2022 May;94(5):2019-2025
pubmed: 34997962
Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Arch Virol. 2022 Apr;167(4):1185-1190
pubmed: 35178586
J Med Virol. 2022 Jun;94(6):2360-2364
pubmed: 35150013
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Nature. 2021 Dec;600(7889):408-418
pubmed: 34880490
Front Microbiol. 2022 Feb 07;12:786233
pubmed: 35197938
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
J Infect. 2021 Aug;83(2):197-206
pubmed: 34089757
Euro Surveill. 2021 Dec;26(50):
pubmed: 34915977
Nature. 2022 Feb;602(7898):657-663
pubmed: 35016194
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
J Med Virol. 2022 May;94(5):1808-1810
pubmed: 35043399
J Med Virol. 2022 May;94(5):2290-2295
pubmed: 35060146
Mol Biol Evol. 2021 Jan 23;38(2):702-715
pubmed: 32941612
J Med Virol. 2022 Jul;94(7):3421-3430
pubmed: 35243660

Auteurs

Philippe Colson (P)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Jérémy Delerce (J)

IHU Méditerranée Infection, Marseille, France.

Mamadou Beye (M)

IHU Méditerranée Infection, Marseille, France.

Anthony Levasseur (A)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.

Céline Boschi (C)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Linda Houhamdi (L)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Hervé Tissot-Dupont (H)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Nouara Yahi (N)

Aix-Marseille Université, INSERM UMR S 1072, Marseille, France.

Matthieu Million (M)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Bernard La Scola (B)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.

Jacques Fantini (J)

Aix-Marseille Université, INSERM UMR S 1072, Marseille, France.

Didier Raoult (D)

IHU Méditerranée Infection, Marseille, France.
Institut de Recherche pour le Développement, Microbes Evolution Phylogeny and Infections, Aix-Marseille Université, Marseille, France.

Pierre-Edouard Fournier (PE)

IHU Méditerranée Infection, Marseille, France.
Assistance Publique-Hôpitaux de Marseille, Marseille, France.
Institut de Recherche pour le Développement, Vecteurs-Infections Tropicales et Méditerranéennes, Aix-Marseille Université, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH